Guorei Yinuo has obtained the Certificate of Conformity to Good Laboratory Practice from the China National Accreditation Service for Conformity Assessment.
Release time:
2023-05-18 12:00
Keywords:
Guorui Yinuo has obtained the Certificate of Conformity to Good Laboratory Practice from the China National Accreditation Service for Conformity Assessment.
On May 4, 2023, Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. (hereinafter referred to as "Guorui Yinuo") obtained the "Good Laboratory Practice Compliance Certificate" issued by the China National Accreditation Service for Conformity Assessment (registration number: CNAS GLP0036). This is another national-level Good Laboratory Practice certificate that Guorui Yinuo has obtained, following its receipt of the "Drug GLP Certification Approval" from the National Medical Products Administration and the GLP supervision and inspection of veterinary drugs by the Ministry of Agriculture and Rural Affairs.
This inspection complies with the Good Laboratory Practice (GLP) principles of the Organisation for Economic Co-operation and Development (OECD). The specific research areas include chemical toxicity studies (research projects encompass: 28-day repeated-dose oral toxicity tests in rodents, acute inhalation toxicity tests, acute skin irritation/corrosion tests, acute eye irritation/corrosion tests, acute oral toxicity tests, acute dermal toxicity tests, and skin sensitization tests); chemical mutagenicity studies (research projects include: in vitro mammalian cell chromosome aberration assays, mammalian erythrocyte micronucleus assays, mammalian bone marrow chromosome aberration assays, and bacterial reverse mutation assays); as well as chemical analytical chemistry and clinical chemistry testing (research project: toxicokinetic studies).
Guorei Yinuo is dedicated to safety evaluation research in areas such as pharmaceuticals, veterinary drugs, chemicals, and cosmetics. We offer clients a one-stop service encompassing personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, and safety evaluations.
Introduction to the China National Accreditation Service for Conformity Assessment:
The China National Accreditation Service for Conformity Assessment (CNAS) is an accreditation body approved and designated by the State Administration for Market Regulation—Certification and Accreditation (CNCA), in accordance with the provisions of the “Regulations of the People’s Republic of China on Certification and Accreditation.” CNAS provides unified accreditation services for relevant organizations, including certification bodies, laboratories, and inspection agencies.
The CNAS Secretariat is located at the China National Accreditation Service for Conformity Assessment, which is affiliated with the State Administration for Market Regulation. It engages solely in accreditation-related activities and does not provide any services that could compromise the impartiality of accreditation.
The National Accreditation System of China for Conformity Assessment holds an important position in international accreditation activities. Its accreditation practices have been integrated into the international mutual recognition system and play a significant role therein. The China National Accreditation Service for Conformity Assessment is a full member of the International Accreditation Forum (IAF), the International Laboratory Accreditation Cooperation (ILAC), the Asia-Pacific Laboratory Accreditation Cooperation (APLAC), and the Pacific Accreditation Cooperation (PAC). As of January 1, 2019, PAC and APLAC merged to establish a new regional accreditation cooperation organization—the Asia-Pacific Accreditation Cooperation (APAC).
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681